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Abstract. We review the current state of research in endoscopic op-
tical coherence tomography OCT. We first survey the range of avail-
able endoscopic optical imaging techniques. We then discuss the
various OCT-based endoscopic methods that have thus far been de-
veloped. We compare the different endoscopic OCT methods in terms
of their scan performance. Next, we examine the application range of
endoscopic OCT methods. In particular, we look at the reported utility
of the methods in digestive, intravascular, respiratory, urinary and re-
productive systems. We highlight two additional applications—biopsy
procedures and neurosurgery—where sufficiently compact OCT-
based endoscopes can have significant clinical impacts. © 2006 Society of
Photo-Optical Instrumentation Engineers. DOI: 10.1117/1.2400214
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Image-guided intervention IGI can be classified into three
categories: image-guided diagnostics IGD,1,2 image-guided
surgery IGS,3–5 and image-guided therapy IGT.1,4,6 The
employment of a particular IGI method depends largely on its
accuracy and its efficacy in a given tissue environment. Medi-
cal imaging techniques such as computed tomography CT,
positron emission tomography PET, ultrasound, and mag-
netic resonance imaging MRI render large volume scans and
can be very useful in certain surgical5,7–9 and therapeutic
procedures.4,6,10,11 As an example, ultrasound image-guided
percutaneous large core needle biopsy CNB for detecting
nonpalpable abnormalities has been gaining popularity due to
the precision ultrasound imaging introduces to the
procedure.12 However, the method is still far from ideal as it is
relatively low in spatial resolution which ranges from
0.1 to 3 mm3.13 Overall, the method does point to the utility
of minimally invasive endoscopic imaging techniques for im-
proving the accuracy and outcome of clinical procedures.
There are two non-optical endoscopic methods that are
worth highlighting: endoscopic MRI and endoscopic ultra-
sonography EUS. Endoscopic MRI probes vary in size ac-
cording to their specific application. For example, MR coils
used to visualize the gastrointestinal GI tract are approxi-
mately 4 cm in diameter,14 while intravascular coils can be as
small as 1.3 mm.15 The in-plane resolution for both probes is
on the order of 150 to 200 m; however, the depth resolution
is in millimeters, e.g., 2 to 3 mm.15 Moreover, the technique
still requires placing the subject inside a large magnet. The
cost and inconvenience of the procedure are significant. In the
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allows for real-time imaging of intraabdominal organs. Two-
dimensional 2D image slices acquired from EUS probes can
be manipulated to render three dimensional 3D viewing of
internal structures as well. Owing to the relatively low e.g.,
110 m axial and 240 m transverse spatial resolution and
low sensitivity of the 25 to 30 MHz EUS probes,16,17 their
efficacy for image-guided intervention, such as for the staging
of tumors, is limited.18 Furthermore, a reduction in ultrasonic
probe size will render even poorer resolution unless the oper-
ating frequency of the ultrasonic probe is also increased at the
same time. An additional challenge for EUS is the need for
acoustic coupling. Clinicians typically submerge the lesion of
interest in water, which may require the patient to be shifted
for water to pool in the appropriate location.19 Alternatively,
some probe designs include water-filled balloons surrounding
the transducer tip, but this necessarily increases the diameter
of the probe.
In comparison, optical imaging techniques that include
conventional endoscopy,20,21 and fluorescence,22 confocal,23
and multiphoton microscopy24,25 as well as optical coherence
tomography OCT26 can offer higher sensitivity as well as
higher spatial resolution. In addition to tissue reflectance, op-
tical methods also enable access to spectroscopic data repre-
sentative of tissue physiological function. The use of inexpen-
sive and nonradioactive optical contrast agents27,28 can also
offer safe, highly sensitive, and targeted imaging of regions of
interest. Other advantages of optical imaging techniques
include portability to low instrumentation cost and operational
cost.
In particular, OCT,26 which is based on low coherence in-
terferometry, can offer high axial resolution, typically
10 to 15 m using superluminescent diodes.29 The depth
penetration of OCT depends on factors such as sensitivity of1083-3668/2006/116/063001/19/$22.00 © 2006 SPIE
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tissue.30 Typical depth penetration of OCT ranges from
1 to 1.5 mm in skin and other highly scattering tissues.31 Re-
cent advancements in OCT imaging strategies have conferred
an additional 20 to 30 dB sensitivity advantage32–34 over the
earlier OCT versions, which can either translate to 1 a
greater depth scan range with a high image acquisition speed
or 2 a decrease in the light fluence level.35,36 OCT also takes
advantage of state-of-the-art laser and fiber-optic technology
developed for optical communications. In this context, the use
of a single-mode fiber for light delivery as well as OCT signal
acquisition has facilitated the development of very small di-
ameter and potentially flexible endoscopic OCT probes for
narrow intraluminal or intracavity imaging.37,38 In this review,
we will survey the state of the art in endoscopic OCT.
This review comprises six sections. In the next section, we
provide a brief survey of optical endoscopic methods. That is
followed by a review of OCT methodology. We then present a
detailed discussion of endoscopic OCT techniques reported so
far, which can be classified into two main categories: side- or
circumferential-imaging and forward-imaging OCT probes.
Before concluding this review, we report on the present appli-
cation areas of endoscopic OCT and explore potential diag-
nostic applications that can benefit significantly from endo-
scopic OCT.
2 Survey of Conventional Optical Endoscopic
Methods
Light-based endoscopy took its first step forward in the 1960s
when fiber-optic endoscopes20 were first introduced. A typical
fiber endoscope uses a fiber-optic cable also known as an
image guide composed of a bundle of glass or plastic fibers
to transfer the image from the distal end to the proximal end
of the endoscope. Such an endoscope has the advantage of
being flexible and can be 1 mm in diameter 19 gauge.39
However, fiber endoscopes of this sort are usually limited in
transverse resolution as they typically render 30 000 resolv-
able points, defined by the number of individual fibers in the
image guide.40 This is equivalent to a 2D image with 150
200 points. In a typical fiber endoscope, the front-end im-
aging lens, usually a gradient index GRIN lens, is glued to
the image guide. Magnifying fiber endoscopes can be realized
by adjusting the distance between the GRIN lens and the fiber
guide. One such proof-of-concept magnifying fiber endoscope
reports a factor of 2 improvement in the lateral resolution
compared with conventional fiber endoscopes.41 It should be
noted that a miniaturized microprecision z-axis controller will
be required to adjust the magnification or the field of view
will be compromised.
In contrast, a different type of imaging devices, collec-
tively known as videoscopes employ charge-coupled devices
CCDs at the distal end of endoscopes. These are commonly
used for image guidance during diagnostic and surgical
procedures,21,42,43 and can be designed to obtain either for-
ward or side images. The resolution of a videoscope largely
depends on the number of pixels in the CCD used. Some
videoscopes are also equipped with a zoom lens at the tip of
the scope, which can yield higher resolution magnified images
of the target tissue; however, this necessarily increases the
size of the videoscope as well. The front end of a videoscope
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CCD size, while the rigid distal portion can be as long as
13.5 mm. Due to their bulky nature, they are difficult to ma-
neuver inside narrower body passageways, limiting their im-
aging capabilities.
Both fiber endoscopes and videoscopes fall into the cat-
egory of white-light endoscopy. They both require additional
waveguides or fibers to shine visible light on the tissue under
examination. Both allow clinicians to visually screen patient
lumens, without any sort of depth perception; therefore, subtle
subsurface lesions can potentially be missed. There are sev-
eral methods for improving the imaging capabilities of white-
light endoscopy. The simplest of these is chromoendoscopy,44
which takes advantage of absorptive dyes or other contrast
agents to enhance visualization with white-light endoscopy.
These dyes are simply sprayed or washed over the tissue of
interest, and a fiber endoscope or videoscope is used to visu-
alize the stained tissue. Additional optical methods for en-
hancing light-based endoscopy include fluorescence
imaging,22 Raman spectroscopy,45 and confocal imaging.23
Fluorescence-based diagnostic techniques are based on the
interaction of light, at specific wavelength, with fluorophores
in the target tissue. Various exogenous fluorophores such as
hematoporphyrin HpD, mono-aspartyl chlorin e6 MACE,
di-aspartyl chlorin e6 DACE, and 5-aminolevulinic acid
5-ALA are available for use in fluorescence-based
imaging.22 In contrast, autofluorescence-based imaging takes
advantage of the natural fluorescent properties of endogenous
tissue fluorophores such as collagen, elastin, nicotinamide,
flavin, and porphyrins.46,47 This technique is a useful diagnos-
tic tool as it is sensitive to the biochemical changes that ac-
company malignant transformation and is thus capable of de-
tecting early stage cancers.46 However, one significant
disadvantage of autofluorescence imaging is that the optimal
excitation and emission wavelengths are dependent on tissue
composition and must be determined for various tissue types
by examining ex vivo samples.47
Raman spectroscopy relies on the change in photon energy,
and corresponding frequency shift, associated with the inelas-
tic scattering of light from the target of interest. Providing
molecule-specific spectral features, this method has the poten-
tial to quantify molecular changes in the target tissue, allow-
ing for the detection of cancerous or precancerous lesions at
much earlier stages.48,49 The challenge associated with this
technique is that the Raman signal of tissue is very weak, and
the signal is often masked by tissue fluorescence.50 Thus far,
Raman spectroscopy has been used to characterize single
points, sampling approximately 500 m in depth.50 One such
fiber-optic probe employed eight fibers, one for the delivery
of light and seven for collection of the Raman signal, creating
a probe tip approximately 1 cm in diameter.50 Additionally,
endoscopic implementations of Raman spectroscopy require
probe design considerations to minimize fluorescence and Ra-
man signals that are generated in the probe itself.50
One major disadvantage of the light-based endoscopes dis-
cussed so far is that they do not offer any sort of depth per-
ception. In this context, two approaches, namely confocal
microscopy23 and multiphoton fluorescence microscopy,24
have been employed to improve the resolution and sensitivity
of conventional fiber endoscopes. Confocal microendoscopes,
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distinguish between structures at different depths, can be fur-
ther categorized into pure reflectance-51 and fluor-
escence-based52 endoscopes. Traditionally, confocal endo-
scopes employ light scanning hardware at the proximal end of
a fiber bundle.53 Depending upon whether a GRIN lens or a
multielement objective lens is used at the distal end, endo-
scopes with outer diameters ranging from 1 to 3 mm have
been reported.51,53 Typical values of transverse and axial reso-
lution for such confocal endoscopes are 3 and 16 m, respec-
tively, with a depth scanning range up to 200 m. Improved
transverse resolution can be achieved by employing a single
fiber with a confocal scanner at the distal end of the endo-
scope. One such reported system is capable of acquiring
stacks of 2D images with a lateral resolution of 0.7 m and
an optical slice thickness of 7 m.52 However, owing to the
difficulty in miniaturizing the raster scanning mechanism, the
endoscope has a 5 mm diameter, with a 43 mm rigid
length.52
In comparison, multiphoton fluorescence microscopy pro-
vides optical sectioning through the sharply decreased excita-
tion rate per fluorophore with axial distance from the focal
plane. However, we note that the group velocity dispersion
GVD and self-phase modulation SPM in standard fibers
pose significant challenges to the development of fiber-based
multiphoton endoscopes.54–56 Solutions to these challenges in-
clude the use of pulse compressors to precompensate the laser
pulses for the effect of GVD,57,58 and the use of SPM-induced
spectral broadening to adjust for pulse broadening due to
GVD.59,60 Two recently reported methods are especially note-
worthy. In the first approach, a photonic band gap fiber is used
for femtosecond excitation light delivery;61 the photonic band
gap fiber transmits femtosecond pulses that are free of SPM as
well as GVD. It is to be noted that the endoscope design uses
a separate high numerical aperture NA multimode fiber for
fluorescence signal collection. Due to the difficulty in minia-
turizing two different light guides, along with beam scanning
hardware at the distal end, the endoscope is bulky
3.5 cm 1.2 cm 1.5 cm in dimension. One recently
developed approach goes away with the optical fiber com-
pletely and instead uses short 1 to 3 cm long rigid GRIN
lenses 350 m to 1000 m in diameter as the light delivery
mechanism. For this case, a laser beam raster directly scans
on the proximal end of the GRIN lens.25,62 The short length of
the GRIN lens keeps the GVD and SPM effects small, but this
approach also limits its application to shallow body parts only
that allow reasonably straight line access to the region of in-
terest such as in laparoscopic procedures.62
We note that by nature of its signal generation process, the
light intensities used in multiphoton endoscopes are signifi-
cantly higher 15 mW focused on a spot size of 1.2 m for
a time duration of 30 s is typical61 than those that are em-
ployed in other methods, with the exception of Raman-based
methods. To the authors’ knowledge, no clinical multiphoton
endoscope studies have been reported thus far.
A final endoscopic method, known as spectrally encoded
endoscopy, uses a broadband optical source coupled with a
diffraction grating via a single-mode fiber.63 The endoscope
design utilizes a diffraction grating that angularly disperses
different wavelengths, which are then focused along a line on
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technique relies on a slow scanning front-end mirror to ac-
quire 2D image data. The researchers have also reported ad-
aptations of the technique for 3D imaging, with axial resolu-
tion of 145 m.64,65 This imaging method is advantageous as
the use of a single fiber allows for much more compact probe
design.
3 OCT: Method Review
Over the past 10 years, OCT has matured into an important
clinical imaging modality as it offers several important advan-
tages. First, OCT has demonstrated the ability to provide high
quality depth-resolved images of biological samples.
Although, the depth scan range of OCT is typically limited
to 2 mm, the high imaging resolution offered by the tech-
nique makes it promising for a variety of diagnostic and sur-
gical applications. Second, owing to the high sensitivity of the
method, the light fluence level required for imaging is low,
allowing its utilization even in sensitive tissue locales such as
the eye.66–68
A typical OCT setup consists of a Michelson interferom-
eter and a low coherence light source. Backscattered light
from the sample interferes with the light collected from the
reference arm, providing depth-resolved structural informa-
tion of the sample There are two main types of OCT
systems—1 time-domain OCT TDOCT26,67,69,70 and 2
spectral-domain OCT SDOCT.71–73
In a TDOCT system shown in Fig. 1a, the reference
arm is typically displaced and scanned over a distance equal
to the depth range, zdepth, that we wish to probe for the
sample. By translating the reference mirror at a uniform speed
and filtering the acquired signal at the induced Doppler shift
frequency associated with the translation speed, we can gen-
Fig. 1 Schematics of a time-domain and b spectral-domain OCT
systems.erate a depth-resolved profile termed A-scan of the sample’s
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ence length lc, which is related to the source bandwidth 
by74
lc = ln2
2

2

. 1
As mentioned earlier, a typical OCT system can offer
10 to 15 m axial resolution using superluminescent diodes.
The development of commercially available broadband light
sources in the near infrared IR band D-series Broadlighters
from SuperlumDiodes, Ltd. has enabled much higher e.g.,
2 to 3 m axial resolution. The use of ultrabroadband light
sources can confer even higher axial resolution.29,75 The high-
est axial resolution demonstrated so far is 0.5 m.76
For a TDOCT system, the filtered interference signal can
be expressed as
Pdetector,z = 2PRoPSo exp−
0
z
a,zs
+ s,zsdzs	R,z
 cos
4
o
zexp− 2 ln22
 z2lc2 	 ,
2
where PRo and PSo represent the optical power in the refer-
ence and sample arms, respectively, and R ,z is the sample
reflectivity at depth z into the sample. a is the absorption
coefficient and s is the scattering coefficient. o is the center
wavelength of the broadband source. The first exponential
term accounts for the loss of collected light due to absorption
and scattering during the passage into and out of the sample.
The convolution with the coherence envelope function im-
plies that only light coming back from within the coherence
gate takes part in the interference. The signal-to-noise ratio
SNR of a typical TDOCT system when using a superlumi-
nescent diode SLD is approximately 90 dB for a typical
power level of 100 W power level, pixel measurement time
of 3 s, and wavelength of 1.3 m. A TDOCT system with
90 dB sensitivity can image as deep as 4.0 mm into a tissue
phantom with 5 mm−1 scattering coefficient. In contrast, a
confocal microscope cannot image deeper than 700 m in a
similar phantom.77
In a typical SDOCT scheme see Fig. 1b, the reference
arm mirror is immobilized and the detector is replaced by a
low-loss spectrometer. The incoming light from sample and
reference arms is spectrally dispersed by the spectrometer
grating and detected using an array of N different detectors,
where N can vary from hundreds to thousands. This type of
SDOCT scheme is also known as spectral radar73 or Fourier
domain OCT FDOCT.78 Mathematically, the spectrally re-
solved interferometric OCT signal at the detector array can be
expressed as
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0
z
a,zs + s,zsdzs	
cos2kz − zr , 3
where k is the wavenumber, Sk is source’s spectral profile,
k is optical power split factor of the 22 coupler 12 in an
ideal case, RR is the reflectivity of the reference mirror,
Rs ,z is the sample reflectivity at depth z. The frequency of
the spectral oscillation of the measured signal in k space is
proportional to the path length difference z−zr between the
reference arm mirror and reflecting plane of interest within
the sample. An interface having a smaller z−zr value pro-
duces a slower sinusoidal spectral oscillation in k space.
Therefore, a Fourier transform of the spectral measurement
will produce an A-scan profile similar to that obtained from
TDOCT. Notice that in this case, signal contribution from two
or more interfaces can be collected simultaneously as they
contribute to different spectral oscillation components. More-
over, the signal from each location z−zr can be detected
over the entire measurement time T. In comparison, a TDOCT
system acquires an interference signal from a location over
much shorter duration, lcT /zdepth. Given the same signal ac-
quisition time T, sample reflectivity Rs, detector quantum ef-
ficiency , and depth scan range zdepth, the respective SNR for
TDOCT and SDOCT systems can be expressed as33
SNRTD =
PsoRs
h	
lcT
zdepth
, 4
SNRSD =
PsoRs
h	
T , 5
where h	 is the energy of photons. For a spectrometer with N
pixels, the highest spectral oscillation periodicity that is de-
tectable is N /2. Beyond that point, the oscillation will wrap
around and create an aliasing signal. Using this criterion, we
see that
k2z − zrmax = 
N2 2⇒ zdepth = N2k . 6
For simplicity, we can consider a rectangular spectral source.
In this case, the coherence length lc is equal to  /k, where
k is the spectral width of the source. Equation 4 can there-
fore be solved to yield lc /zdepth=2/N. Hence, Eq. 4 can be
rewritten as
SNRTD =
PsoRs
h	
T
N/2
. 7
A comparison of Eqs. 5 and 7 indicates that for a rectan-
gular spectral source, a SDOCT system is intrinsically more
sensitive than a TDOCT system by a factor of N /2.34 For a
Gaussian source, the SNR advantage of SDOCT over TDOCT
is expected to be N /4.34 This illustrates that for a given source
power, sample reflectivity, and A-scan rate, a spectrometer-
based SDOCT system with N=2048 pixels can, in principle,
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terpart TDOCT system.
Notice that the spectrometer in the above SDOCT scheme
essentially samples the spectral oscillations at approximately
evenly spaced wavelengths. The spectral data is usually res-
caled and resampled evenly in wavenumber space, before it is
Fourier transformed to get the sample depth profile or A-scan.
An alternative method would be to use a rapidly tuned nar-
rowband source and measure the spectral oscillations at
evenly spaced wavenumbers. The interference signal can be
detected by a single detector or dual balanced detectors. This
approach to SDOCT, which has been termed optical fre-
quency domain reflectometry OFDR,71 wavelength tuning
interferometry WTI,72 and optical frequency domain imag-
ing OFDI,65 offers a similar sensitivity advantage over the
conventional TDOCT as its counterpart spectrometer-based
SDOCT. A typical SDOCT system can achieve a SNR of
about 120 dB. This improved sensitivity can be traded off in
favor of shortened signal acquisition time. For instance, Cense
et al.36 have shown an OCT data acquisition rate of 29300
spectra per second, with 89 dB measured SNR, using a
spectrometer-based SDOCT system. Recently, researchers at
Massachusetts General Hospital79 and at Massachusetts Insti-
tute of Technology MIT80 have reported ultrahigh-speed
wavelength-swept sources that can enable OCT data acquisi-
tion at 115 and 290 kHz A-scan rates. This illustrates the
potential of SDOCT-based systems to provide real-time imag-
ing of tissue structures. However, we note that SDOCT-relies
on computationally intensive Fourier transforms to deliver the
final structural image of the biological sample. It is, therefore,
important to introduce high-speed signal processing modules,
such as field programmable gate arrays FPGAs81 to acquire
and process the OCT data in real time for true video-rate
imaging.
Finally, we note that while a basic OCT imaging method is
able to render depth-resolved structural images of biological
samples, more sophisticated OCT imaging strategies can pro-
vide additional functional information, such as flow through
Doppler OCT,82,83 tissue structural arrangement through bi-
refringence OCT,84,85 depth-resolved spectral signatures
through spectral OCT,86,87 and the spatial distribution of
specific contrast agents through molecular contrast OCT.28,88
4 Survey of Endoscopic OCT Methods
The relative ease of implementing high-speed and high-
resolution OCT systems has prompted numerous efforts to
implement OCT-based endoscopes. The primary design con-
sideration is to minimize the diameter of the OCT probe. To
this end, the single-mode fiber used for light transmission in
most OCT systems is ideally suited for the purpose. Other
important technical characteristics of an OCT probe are
scanning range, field of view, speed, and flexibility. OCT
probes can be divided into two groups based on their
scan modes—side-imaging37,89–97 and forward-imaging
probes.38,98–107 In the past years, various OCT probes have
been built to target specific applications, which we will dis-
cuss below.
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The majority of the endoscopic OCT systems reported in the
literature are side-scanning. In these systems, the OCT probe
light is emitted from and collected at the side of the endo-
scope. The general design of such a probe consists of a rod
mirror or prism attached to a rotation assembly to deflect the
emitted light from the optical fiber tip out of a window on the
side of the probe. Side-imaging probes can be further divided
into two categories: 1 circumferential and 2 linear or
translational scanning probes.
The first side-imaging OCT probe was a collaborative
work of researchers at MIT and Massachusetts General
Hospital.37 The rotation was achieved by attaching the proxi-
mal end of the flexible probe to a motor and a gear system
see Fig. 2a. At the distal end, the laser beam was focused
by a GRIN lens attached to an optical fiber, and then reflected
by a right angle prism as shown in Fig. 2b. The outer diam-
eter and working distance of the OCT probe were 1.1 and
2.5 mm, respectively. Later, a similar but smaller side-
imaging OCT probe was built within a 27 gauge
410 m hypodermic needle.89 Yang et al. have also dem-
onstrated the use of angle-cut ball-lens fibers see Fig. 2c to
realize the tip of side-imaging OCT endoscopes.90
Another approach to building circumferential-imaging
OCT probes is to employ the actuation system at the distal
end. In this context, Tran et al.91 and Herz et al.92 reported,
almost at the same time, the use of micromotors at the distal
end of OCT probes in order to achieve circumferential scan-
ning; the outer diameters of the reported OCT probes were
2.4 mm91 and 5 mm.92 A representative schematic of a
micromotor-based OCT endoscope91 is shown in Fig. 2d. It
is to be noted that the distal actuation of the probe tip avoids
the rotation of the whole probe and the necessity to couple
light from a fixed fiber to a rotating fiber. However, the size of
the actuator itself can be a limiting factor when minimizing
the overall OCT probe size.
Besides rotation, the linear translation of the OCT probe
can also be used to achieve side imaging. Researchers from
Harvard Medical School and Massachusetts General Hospital
developed a linearly translating OCT endoscope;93 the angular
displacement of a galvanometer shaft was converted into lin-
ear displacement of the OCT probe see Fig. 2e. Later,
Yang et al.95 used an actuation system similar to that shown in
Fig. 2e to realize a longitudinal scanning side-imaging OCT
endoscope for in vivo Doppler imaging. Other adaptations of
linearly scanning OCT probes include the use of a magnetic
actuator94 or a linear galvanometer96 at the proximal end. It is
to be noted that the distal end of all the linearly scanning
probes mentioned above was identical to that shown in Fig.
2b. Recently, Tumlinson et al.97 have reported a longitudinal
scanning endoscope that also houses an interferometer at the
tip of the probe see Fig. 2f to eliminate dispersion and
polarization mismatch between sample and reference arms for
high-resolution endoscopic FDOCT. The endoscope features a
2 mm outer diameter, 20000 A-scan rate, and 2 mm/s linear
scan speed.
We note that all side-imaging OCT probes are essentially
2D in nature, although the combination of circumferential im-
aging and the back and forth translation of the probe may
94generate 3D images as well. The size of reported side-
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upon the type and location of the rotation assembly employed.
Figure 3 shows an in vivo OCT image of hamster leg muscle
acquired with the smallest 0.4 mm diameter reported
circumferential-scanning OCT probe.89 The features of differ-
ent side-imaging OCT probes reported to date are summarized
in Table 1.
It is to be noted that Table 1 registers the achieved param-
eters for each of the side-imaging probes that have been re-
ported in literature. While the numbers provide convenient
points of reference, they do not represent the achievable lim-
its.
Fig. 2 Designs and actuation systems of side-imaging OCT probes. P
ferential and longitudinal scanning, respectively. Portions b, c, an
probes. Portion d shows the design of a circumferential-scanning en
Fig. 3 In vivo OCT image of hamster leg muscle acquired with the
smallest reported side-imaging OCT needle. The muscle fascicles can
clearly be recognized. Arrows indicate layered structure resulting
from muscle birefringence. Scale bar is 500 m. Image acquired from
Ref. 89.
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In contrast to side-imaging OCT endoscopes, forward-
imaging OCT endoscopes emit and collect light in front of the
probe; hence, they can be very useful in providing tissue
structural information forward of a catheter probe for image
guidance during surgery or device placement. Unlike side-
imaging OCT systems, the implementation of a forward-
imaging system within a narrow probe is more technically
challenging; unsurprisingly, the forward-imaging probes re-
ported so far are relatively large e.g., 1.65 to 7.5 mm in
diameter.38,98–107
In 1997, Boppart et al. reported 6.4 mm diameter lead zir-
conate titanate PZT cantilever-based handheld forward-
imaging instruments for open-field and minimally invasive
surgical procedures.38 In one design see Fig. 4a, the PZT
cantilever was used to translate a fiber and a GRIN lens to-
gether for output beam scanning. Although, the fiber–GRIN
lens assembly itself was compact, the overall size of the
forward-imaging instrument was significant mainly due to the
large diameter of the PZT cantilever. In the other design,
shown in Fig. 4b, the fiber–GRIN lens assembly was trans-
lated in the image plane of a long 19.5 cm rod lens to real-
ize a rigid forward-imaging OCT probe for laparoscopic pro-
cedures. The probe featured a 5 mm working distance with a
2 mm lateral scan range. Later, Liu et al.98 demonstrated the
use of a smaller 1.5 mm diameter PZT actuator to scan a
fiber in front of a stationary GRIN lens for output beam scan-
ning see Fig. 4c. As opposed to the earlier designs reported
in Ref. 38, the OCT endoscope utilized a resonant scanning
a and e show actuation systems at the proximal end for circum-
how the reported distal-end probe tip designs for side-imaging OCT
ic OCT probe with actuation system at the distal end.ortions
d f smode that allowed very fast 1.4 kHz lateral scanning of
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Downloaded the probe beam. The overall diameter of the fiber-optic OCT
endoscope was 2.4 mm with lateral scan range of 2.5 mm,
whereas the length of the distal rigid portion was 3.2 cm.
In retrospect, Sergeev et al. reported the first fiber-based
forward-imaging OCT endoscope.99 The endoscope design
utilized an electromechanical unit at the distal end in order to
move a fiber tip in the imaging plane of a stationary lens
system to realize a 2.2 mm diameter forward-scanning flex-
ible OCT probe. A galvanometer–scanner based rigid arthro-
scopic OCT probe with 6 mm lateral scanning range has
also been reported.100 Instead of deflecting the fiber tip at the
distal end, the galvanometer was used to scan a collimated
beam in front of a lens, placed one focal length distance away
from the galvo scanner, to achieve linear scanning of the out-
put beam see Fig. 4d. The rigid elliptical scope sheath
cross section was 7.5 mm along the scan direction.100
Another class of forward-imaging probes is based on the
use of microelectromechanical systems MEMS–based mir-
rors at the distal end for output beam scanning. Typically,
light from the sample arm fiber is collimated before it enters a
beam folding optics, where one element consists of a MEMS-
based scanning mirror; the scanning optical beam is then fo-
cused by a scan lens see Fig. 4e for a representative sche-
matic. Two such OCT endoscopes have reported the use of
flapping MEMS mirrors, with a bimorph thermally actuated
contraction hinge at one end.101,102 The MEMS-based endo-
Table 1 Comparison of different side-imaging en
using OCT system specifications; A/s: A-scans pe
Design Scheme
Size
mm
Combination of Figs. 2a and 2ba 1.1
Combination of Figs. 2a and 2bb 0.4
See Fig. 2dc 2.4
Similar to Fig. 2dd 5
Combination of Figs. 2a, 2b, and 2ee 1.5
Combination of Figs. 2b and 2cf NA
Combination of Figs. 2b and 2cg 2
Combination of Figs. 2b and 2ch 2
Combination of Figs. 2c and 2ei 0.9
Combination of Figs. 2e and 2fj 2
aReference 37.
bReference 89.
cReference 91.
dReference 92.
eReference 94.
fReference 93.
gReference 95.
hReference 96.
iReference 90.
jReference 97.scopes were 5 mm in diameter, with lateral scan range of
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also reported a MEMS scanner, with a pivot point in the
middle of the mirror, for endoscopic OCT; an integrated force
array IFA linear actuator attached at one end of the mirror
was used to pull and tilt the mirror for beam scanning see
Fig. 4f. The MEMS mirror was incorporated into an experi-
mental OCT system for proof-of-concept demonstration; how-
ever, the scanner will need to be modified and packaged ap-
propriately if it is to be used in endoscopic applications.103
In addition, a two-axis MEMS mirror at the distal end can
also be used to acquire 3D OCT images.104 In this respect,
Yeow et al. have reported proof-of-concept 3D OCT imaging
of a fruit fly using a 2D MEMS scanner actuated by electro-
static forces.105 Another noteworthy effort in this direction
reports the use of a 2D MEMS mirror for 3D OCT imaging a
of a hamster cheek.108 However, further technology develop-
ment is required to incorporate the scanner into an OCT probe
for endoscopic applications. We also note that the MEMS-
based probes are generally large in size, limiting their appli-
cation to relatively large body passageways. Recently, one
approach to 3D OCT imaging has reported the use of 2D
beam scanning at the proximal end of a fiber bundle see Fig.
4g; a unity magnification lens–imaging system at the distal
end was employed to focus the probe beam on the tissue
sample.106 We note that although this probe design is capable
pic OCT probes. NA: Not available, **: Estimated
nd.
lution m Working
Distance
mm
Angular
or Lateral
Scan
Range Speedal Lateral
38 2.5 360° 1 rpm
17 0.08 360° NA
** 13 2 360° 1000 A/s
8 variable 360° 2000 A/s
15 0.5 35 mm 3125 A/s
30 0.7 5.5 mm 1700A/s**
3 NA NA 2 mm 8000 A/s
18 0.3 6 mm 14 A/s
3 26 0.35 2.5 mm 4800 A/s
10 0.3 
2.5 mm 20000 A/sdosco
r seco

Reso
Axi
20
6.7
9.5
5
5
9.3
1
16
1
2.4of acquiring 3D images, only 2D images were reported.
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ported a design for a forward-imaging OCT needle probe,
termed “paired angle rotation scanning PARS OCT probe.”
As shown in Fig. 4h, this probe design utilizes a pair of
angle-cut rotating GRIN lenses to deflect and scan the OCT
probe beam across the forward region ahead of the probe tip.
In this design, the scan actuation system may be located far
from the probe tip, much like in the case of the side-imaging
OCT probe described in Ref. 37, enabling easy miniaturiza-
tion of the actual probe. Moreover, due to the nature of the
Fig. 4 Forward-imaging OCT probes. a Hand-held OCT probe. b R
scanning miniature OCT endoscope. d Galvo scanner-based linear
scope, where f shows a MEMS mirror with pivot point in the middle
of PARS-OCT probe showing profile of PARS-OCT B-scan mode. i Rel
single-mode fiber; BS: beamsplitter; L: lens; PBS: polarization beamsp
gear; IFA: integrated force array; GL: GRIN lens.scan mechanism, the lateral beam scanning at the exit face of
Journal of Biomedical Optics 063001-
From: http://biomedicaloptics.spiedigitallibrary.org/ on 10/05/2016 Terms of the probe is minimal. This allows for maximization of the
probe NA for a given probe size and working distance. Figure
5 shows OCT images of a tadpole acquired with the
PARS-OCT—the smallest 1.65 mm diameter forward-
imaging probe reported so far.
Recently, Xie et al.109 have reported a rigid OCT endo-
scope with fast dynamic focus tracking to improve lateral
resolution see Fig. 4i. The probe design utilizes relay
GRIN lenses similar to that in multiphoton endoscopes25,62
and OCT laparoscopes,38 shown in Fig. 4b, for light deliv-
CT laparoscope for minimally invasive procedures. c Flexible rapid
ng hand-held OCT scope. e Schematic of MEMS-based OCT endo-
mirror. g Fiber bundle based–OCT endoscope design. h Schematic
IN-based rigid OCT endoscope with fast dynamic focus tracking. SMF:
PZT: lead zirconate titinate; CM: Fiber-optic collimator; F: ferrule; G:igid O
scanni
of the
ay GR
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proximal end of a relay GRIN lens for lateral beam scanning
on the sample. Forward-imaging imaging of rabbit trachea ex
vivo has been demonstrated using a 2.7 mm diameter OCT
probe. The group has also demonstrated a 4.5 mm diameter
hybrid OCT probe design that employs a right-angle prism in
the front to translate forward scanning into side scanning.
We note that besides PARS-OCT,107 endoscope designs
based on 2D MEMS mirrors,104,105 fiber bundles,106 and relay
GRIN lenses109 are capable of 3D endoscopic OCT imaging.
All other forward-imaging probes are essentially 2D in nature;
although a combination of 2D forward scanning and probe
rotation can also be used to obtain 3D OCT images. Recently,
Myaing et al.110 have reported the development of a
Fig. 5 OCT images of the dorsal region of a stage 54 xenopus laevis
tadpole acquired using PARS-OCT the smallest forward-imaging OCT
probe reported so far. Images acquired from Ref. 107.
Table 2 Comparison of different forward-imaging endoscopic OCT
*: Lateral scan rate; A/s: A-scans per second.
Design Scheme
Size
mm
Resolu
Axial
See Fig. 4ba 
2.68 12
See Fig. 4cb 2.4 25
Probe design not availablec 
2 10**
See Fig. 4dd 7.53
oval
10
See Fig. 4ee 5 10
See Fig. 4ef 5 10
See Fig. 4gg NA 10
See Fig. 4hh 1.65 9.3
See Fig. 4ii 2.7 10
Right-angle prism in front of
design shown in Fig. 4ii
4.5 10
aReference 38.
bReference 98.
cReference 99.
dReference 100.
eReference 101.
fReference 102.
gReference 106.
hReference 107.
iReference 109.
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cence imaging. The 2D beam scanning was achieved by vi-
brating the fiber cantilever near its mechanical resonant fre-
quency in a spiral scanning fashion. It is to be noted that the
scanning mechanism of this endoscope is an adaptation of an
earlier resonant scanner–based endoscope design for OCT,98
which yields beam scanning primarily in one dimension. Al-
though this study was aimed at two-photon fluorescence en-
doscopy, we note that the probe design is very much suited for
3D forward-imaging endoscopic OCT.
Table 2 summarizes the features of different forward-
imaging endoscopic OCT probes reported to date. The achiev-
able lateral scan range for a given working distance, probe
numerical aperture, and probe size are all relevant specifica-
tions that need to be considered when designing probes for
specific applications.
5 Application Areas of Endoscopic OCT
OCT has matured into an important imaging modality since
its invention in 1991 and has been extensively applied in oph-
thalmology settings. The popularity of the method lies in the
numerous advantages that it offers—high detection sensitivity
allowing low light fluence levels, fast imaging speed, and
high spatial resolution. The development of endoscopic OCT
probes has opened up several application areas where this
new imaging modality can make a large clinical impact. As
. NA: Not available; **: Estimated using OCT system specifications;
m Working
Distance
mm
Lateral
Scan
Range
mm SpeedLateral
33 5 2 NA
16 3.5 2.5 2.8 kHz*
20 5 2 100 A/s
17 NA 6 2400 A/s
20 NA 2.9 2400 A/s
20 NA 4.2 2400 A/s
12 NA 2.8 NA
10 1.4 0.93** 250 A/s
10 0 to 7.5 2.7 4096 A/s
10 0 to 7.5 4.5 4096 A/sprobes
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suitable for imaging within a tubular organ, such as the vas-
cular system, the gastrointestinal tract, the breast duct, and the
urinary tract. In comparison, forward-imaging OCT probes
can be very useful in providing tissue structural information
forward of the catheter probe, such as for image-guided bi-
opsy or device placement.
The probe design considerations are considerably different
in either case. Imaging within a tubular organ generally re-
quires the probe to be more flexible so that it can conform to
the curvature of the tubular organ. The probe size can be fairly
large 1 centimeter for some of the large tubular organs
such as the esophagus. In addition, it is generally the walls of
the tubular system that is of clinical interest while the pas-
sageway itself is of little significance. Therefore, a side-
imaging probe is more relevant in this context. In comparison,
imaging needs associated with incision-based procedures gen-
Table 3 Probe and needle sources for common clinical and/or surg
information is from various sources on the Web and various clinician
Diameter mm
Needle
Gauge In
10 ranges widely G
7 ranges widely L
6 B
3.40 10
3.05 11
2.77 12
2.41 13
2.11 14 Cor
1.83 15
1.65 16
1.47 17 Cor
1.27 18
1.07 19
0.90 20 Mam
0.81 21 S
0.71 22
0.64 23 S
0.56 24
0.51 25
0.46 26
0.41 27
0.36 28
0.33 29 S
0.31 30
0.25 31
0.23 32
0.20 33
0.14 35
aReference 107.
bReference 89.erally place more emphasis on the region ahead of the needle
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should be much stiffer, and small diameter probes are greatly
desired in this context. As a guide for researchers working
toward different OCT endoscope designs, Table 3 shows the
size range of probes and needles that are presently used in the
clinical setting.
In this section, we review the endoscopic OCT studies per-
formed so far. We note that most of the works that have been
reported are preliminary and are primarily focused at estab-
lishing the viability of using OCT-based endoscopic systems
to perform imaging of the specific target areas. In the majority
of the cases, systematic verifications of the utility of these
endoscopes for clinical applications remain to be done. In
addition to surveying the existing works, we will also high-
light a few application areas in which we believe endoscopic
OCT can play an important role.
rocedures. The needle gauge table is from Ref. 194. The rest of the
urgeons see acknowledgment.
nt Type Application
scope GI endoscopy
scope Laparoscopy
scope Bronchoscopy
sy needle Typical breast core biopsy needle
Narrowest reported forward-imaging
probea
sy needle Typical liver core biopsy needle
uctoscope Breast ductoscopy
needle Typical size for drawing blood
needle Typical size for injection including
anesthesia
Narrowest reported side-imaging
probeb
needle Typical size for insulin injection
Narrowest commercially available
needleical p
s and s
strume
I endo
aparo
roncho
e biop
e biop
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yringe
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5.1.1 GI tract
The GI tract is the first internal organ for which endoscopic
OCT was applied to study.69 The GI tract is well suited for
endoscopic OCT applications for several reasons. First, the
tract is wide typically a few centimeters. It can, therefore,
accommodate fairly large endoscopic probes with little ill ef-
fects. Second, the initial section of the GI tract—the
esophagus—is fairly straight. This implies that fairly rigid and
straight endoscopes can be used in this section without many
complications. Third, there is a significant range of disease
conditions that can arise in the GI tract for which the ability to
obtain depth-resolved images can be of clinical significance
and diagnostic utility. Examples of such conditions include
Barrett’s esophagus,111 ulcerative pancolitis,112 and
cancer.113–115
An area of significant clinical interest is staging GI cancer.
Patients with chronic GI disorders can develop precancerous
conditions, which may then progress into cancers. Most of the
neoplastic changes in GI originate in the mucosal region—a
region that extends from the surface of the GI to a depth of
1.5 to 2 mm.99 Therefore, the ability to image mucosal and
submucosal layers with sufficient resolution is extremely im-
portant to determine abnormal tissue structural changes. Di-
agnostics of patients with GI disorders are available through
techniques such as endoscopy, EUS, CT, and MRI. However,
owing to low spatial resolution, they do not render the image
quality that is available with OCT.116
Izatt et al.117 first demonstrated the ability of OCT to ob-
tain cross-sectional images of the GI tissues with excised in
vitro GI tissue specimens; a closely related work was also
reported by Tearney et al. Ref. 118 is the most relevant
among several others. The work is significant in establishing
that OCT is able to distinguish the different tissue layers. It
also provides the first evidence that invasive adenocarcinoma
can be detected based on the disruption of the normal mucosal
structure. The first demonstration of in vivo imaging of GI
tissues using a circumferential side-imaging endoscopic probe
design shown in Figs. 2a and 2b was reported by Tearney
69
Fig. 6 In vivo OCT imaging of the rabbit esophagus. A shows differen
sm, the inner muscular layer im, the outer muscular layer om, the
blood vessel v within the submucosa of the esophagus. C Correspo
acquired from Ref. 69.et al. Figure 6 shows high-resolution in vivo OCT images of
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OCT to delineate inner mucosal and submucosal layers of
esophagus. Later, Bouma et al.93,119 demonstrated OCT imag-
ing of a normal human esophagus in vivo using a longitudinal
scanning side-imaging endoscopic OCT probe. In vivo endo-
scopic OCT studies of a human stomach115,120 and human bile
duct121–124 have also been reported.
Vitkin’s group has also explored the incorporation of Dop-
pler OCT functionality into their endoscopic probe systems
for imaging the GI tract in rats and humans.95,125 Their work
indicates that microvascular changes during disease progres-
sion can be detected and potentially may serve as diagnostic
markers with the use of Doppler OCT. The inclusion of Dop-
pler OCT imaging capability entails a modification in the way
the acquired OCT signal is processed and does not require a
modification of the probe design. As such, we expect the in-
clusion of Doppler OCT imaging capability in any prospec-
tive endoscopic probes will be driven by the usefulness of the
functionality, as opposed to any technical implementation
difficulties.
It is to be noted that most of the reported endoscopic stud-
ies in the GI tract have used side-imaging endoscopes; this is
due to the tubular structure of the GI tract, which makes side-
imaging OCT endoscopes more suitable for imaging. One
possible use of forward-imaging OCT probes in the GI tract
will be as a guidance tool for image-assisted biopsies. A side-
imaging OCT probe is less suitable in this context as the
probe will occlude the region of interest.
5.1.2 Vascular system
The vascular system is the other major area in which OCT
endoscopy has been evaluated and studied for use. The focus
of the reported studies is primarily on evaluating the use of
OCT to aid in diagnosing coronary artery disease.
Coronary artery disease often results from a condition
known as atherosclerosis126,127—a process in which deposits
of fatty substances, cholesterol, cellular waste products, cal-
cium and other substances build up in the inner lining of
arteries. This build-up, also known as stenotic lesion, can
s of rabbit esophagus, which include the mucosa m, the submucosa
s, and the adipose and vascular supportive tissues a. B shows a
histology for B hematoxylin and eosin stain; bars, 500 m. Imagest layer
serosa
ndinggrow large enough to block or significantly decrease the flow
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Downloaded of blood through an artery.128,129 Sometimes, atherosclerotic
lesions can rupture soft or vulnerable plaques causing blood
clots that may result in arterial occlusion.128,129 Current imag-
ing techniques, such as angiography,130,131 are capable of de-
tecting stenotic lesions also classified as hard plaques, so
that intervention such as angioplasty or stenting can take
place.132 However, these techniques have difficulty detecting
and distinguishing lesions classified as vulnerable or soft
plaques,129 which have little to no effect on blood flow and yet
can often result in sudden death when they rupture.133 It is
therefore important to be able to highlight the presence of
such high-risk stenotic lesions at an early stage. Studies have
shown that vulnerable plaques have certain features, such as a
thin fibrous cap with thickness of 65 to 150 m a feature
size well suited for OCT,134 large lipid core, and elevated
macrophage content inside the fibrous cap.129
Side-imaging endoscopic OCT is shown to be extremely
useful for imaging inner layers of the vascular system. In this
respect, Brezinski et al.17,135 were the first to compare endo-
scopic OCT and intravascular ultrasound IVUS imaging for
assessment of atherosclerotic plaque morphology in vivo. Jang
et al.136 have shown that OCT, owing to its superior resolu-
tion, provides additional morphologic information such as
identification of intimal hyperplasia, internal and external
elastic laminae, and echolucent lipid-rich regions not detect-
able with IVUS. This additional information has proven to be
useful for improved characterization of different plaque
types.137 Two recent studies have compared OCT with other
Fig. 7 Examples of a occlusion and b angioplasty balloon cathete
lesions in cadaver arteries. Images acquired from Ref. 140.imaging modalities including IVUS, palpography, thermogra-
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individual characteristics of vulnerable plaques.138,139 In an-
other article, Schmitt et al.140 have compared various tech-
nologies such as angioscopy, angiography, electron beam CT,
and IVUS with intravascular or intracoronary OCT a com-
mercial system from LightLab Imaging, Inc.. The outer di-
ameter of the OCT probe distal tip was 0.36 mm design
shown in Fig. 2b. Figure 7c shows in vivo OCT images
and corresponding histology of coronary lesions in cadaver
arteries. A good correlation between the OCT images and cor-
responding histology indicates the ability of endoscopic OCT
to diagnose arterial atherosclerosis with high precision. Com-
pared with IVUS, OCT also provides more accurate assess-
ment of coronary intima-media thickness.141 Since intimal
thickening is considered to be an early phase of atherosclero-
sis, the use of intravascular OCT may prove to be useful for
early prognosis of the coronary artery disease. The usefulness
of intracoronary OCT for assessment of vulnerable plaques
through the quantification of macrophage content and its dis-
tribution has also been demonstrated.142–144 Tearney et al.145
have also reported on the characterization of vulnerable
plaques based on spatial and temporal speckle analysis of
lipid-rich plaques.
Another important application of endoscopic OCT technol-
ogy for vascular imaging is for monitoring intracoronary
stents. Stent implantation, commonly guided by IVUS, could
benefit from the higher resolution of OCT to identify poorly
placed stents. Additionally, intravascular OCT can be useful
Comparison of OCT images right and histology left of coronaryrs. cin identifying regrowth of the vessel that may lead to
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IVUS images acquired in the coronary arteries.146
Looking ahead into the near future, we believe a poten-
tially important use of endoscopic OCT is to aid in thrombus
clot removal in patients with ischemic strokes. Forward-
imaging OCT probes can be used to image the extent of the
thrombus and determine the best approach for removal. Acute
ischemic strokes can be classified into subcategories such as
large-artery atherosclerosis, cardioembolism, and small-artery
occlusion lacune.147 Lacunar infarction also known as
small-vessel thrombosis represents as high as 23% of all the
cases of cerebral infarction.148 The physical constraints on the
OCT probes for imaging a single, deep-penetrating small ar-
tery, typically 500 m in diameter 0.35 mm, as indi-
cated in Ref. 149, are necessarily more stringent. In addition
to small size, the OCT probes for lacunar thrombus removal
will also need to be more flexible as these finer blood vessels
are more prone to perforation.
5.1.3 Respiratory system
The respiratory system is another venue in which OCT endo-
scopic methods can have significant clinical utility. The sys-
tem is readily accessible and there are a range of pathological
conditions that can benefit from endoscopic OCT imaging.
These conditions include sleep apnea,150 laryngeal
carcinoma,151 and bronchial inflammation.152 The dimension
of the air passageway ranges from 2 cm in the trachea153 to
1 to 2 mm in the terminal bronchioles.154 Flexibility of the
probe is of great significance in this case as the finer bronchi-
oles are delicate.
There are several preliminary studies with excised tissue
samples. Pitris et al. established that OCT can indeed delin-
eate the epithelium, mucosa, cartilage, and glands in samples
from the upper respiratory tract in 1998.155 Yang et al. fur-
thered this line of research by imaging the main and tertiary
bronchi.156,157 The same group has also demonstrated that the
carbon residuals from smoking function as a natural contrast
agent in smokers’ lungs.158
Of particular interest is the report by Hanna et al.108 in
which they demonstrated the use of a 2 mm diameter side-
imaging OCT probe design shown in Fig. 2b for 2D and
3D imaging of airway, lung, and pleura. In addition to in vivo
imaging of animals rabbit and pig, the researchers have also
reported OCT catheter-based clinical bronchoscopies in hu-
159
Fig. 8 A Optical coherence tomographic image showing tissue pro-
lapse indicated by filled arrow. The open arrow points to an under-
deployed stent. B shows the corresponding IVUS image, indicating
the inability of IVUS to resolve such small features. Images acquired
from Ref. 146.man patients. Recently, Tsuboi et al. have demonstrated
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chial lumens in vivo. These studies show the capability of
endoscopic OCT to diagnose lesions in respiratory system
without requiring excisional biopsies.
5.1.4 Urinary and reproductive tract system
The urinary and reproductive tract system is the final area that
we discuss in the context of tubular organs. This is yet another
area in which endoscopic OCT tools can potentially play a
significant diagnostic role and in which relatively little OCT-
related research has been reported.
The range of disease conditions that can potentially benefit
from early and noninvasive diagnosis with OCT-based imag-
ing include various gynecologic cancers which arise in the
vulva, vagina, and cervix,160–162 prostate cancer,163,164 and
urinary bladder cancer.165 The regions of interest have also
been surveyed with excised samples over the past decade by
various research groups. Some of the noteworthy reports in-
clude Ref. 166 for the urinary tract, Refs. 166–168 for the
bladder, Ref. 169 for various gynecologically relevant re-
gions, and Ref. 170 for the prostate.
Sergeev et al.99,171 demonstrated the use of a forward-
imaging OCT probe for in vivo imaging of healthy as well as
cancerous human cervix and endometrium. To our knowledge,
this is the first in vivo study of the human reproductive sys-
tem. Later, Jesser et al.172 reported the use of a side-imaging
OCT probe see the probe design in Fig. 2b for evaluation
of bladder pathologies; in addition to OCT imaging of rabbit
bladder in vivo, bladder specimens obtained from autopsy
were also used in the study. A more far-reaching clinical study
conducted by Russian researchers173,174 has reported the suc-
cessful use of 2.7 mm outer diameter forward-imaging OCT
probe, passed through the operating channel of a cystoscope,
to image and evaluate mucosal sites of interest. The study
indicates that endoscopic OCT may also be useful as an
image-guidance tool for biopsy and surgical procedures of
bladder.
5.2 Image-Guided Surgical Incision Procedures
5.2.1 Ovarian system
Unlike most of the other parts of the reproductive system,
clinical access to the ovaries is most easily gained through a
surgical incision in the abdominal wall. Though ovarian
cancer175 is rare, it has the highest mortality rate among the
gynecological cancers.176 The ability to optically image and
determine potential cancer formations on the ovary through a
laparoscope can significantly improve the clinical accuracy of
a diagnosis. In the context of endoscopic OCT imaging, a
forward-imaging system would be a more suitable choice in
this situation.
The significance of this application was recognized fairly
early in the development of forward-imaging OCT probe.
Boppart et al.38 reported the first in vitro images of human
ovary and uterus tissue using a forward-imaging rigid OCT
laparoscope in 1997. More extensive research was reported in
Ref. 176 by a different group Brewer et al.. The data was
acquired from excised tissues. The later report strongly indi-
cated that cancerous tissues are easily distinguished with OCT
imaging.
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The number of breast and liver biopsies performed per year is
notably high. For breast cancer biopsy procedures alone, the
number stands at approximately 1.2 million per year.177
The means for guidance of the biopsy needles to the ap-
propriate tissue locales have significant drawbacks. For ex-
ample, x-ray mammography,178,179 which enables image
guided stereotactic breast biopsy, entails the usage of radia-
tion that is harmful at high dosages. Ultrasound tomography
methods have also been used in needle surgical
procedures;180,181 however, the low-resolution 100 m
limits its efficacy. OCT image guidance can potentially in-
crease the accuracy of the biopsy by identifying anomalous
tissue regions prior to the actual tissue extraction. The poten-
tial of such guidance is illustrated by a recent in vitro pilot
study with a rat mammary tumor model performed by Bop-
part et al.,182 in which they showed that breast cancers can be
readily identified with OCT. In addition to providing image
guidance for conventional biopsy procedures, OCT’s ability to
render high-resolution images can also be potentially used as
a means to evaluate tissue status without the need for biopsy.
The need for some form of forward guidance in biopsy
procedures has prompted Iftimia et al.183 to evaluate the use of
a non-imaging OCT needle probe 23 gauge system that is
capable of taking a single A-scan into the tissue for breast
aspiration biopsies. In this context, the development of narrow
OCT endoscopes with 3D forward imaging capability is ex-
pected to improve the accuracy and effectiveness of such bi-
opsy procedures. It is to be noted that the needle size require-
ments of such procedures 14 gauge for breast biopsies and 17
gauge for liver biopsies has already been met by some of the
reported forward-imaging OCT endoscope designs.107 We ex-
pect to see such applications in the near future.
5.2.3 Brain surgery
One final area that we draw attention to is brain surgery. Brain
surgery is performed in an event of penetrating head
injuries,184 brain-related disorders such as hydrocephalus,185
cerebral aneurysms,186 etc., or brain tumors. Surgery related
to brain tumors can be aimed to perform a biopsy or remove
the tumor, although the cure rate depends on the complete
removal of the tumor, as well as postsurgical therapeutic treat-
ments. Imaging modalities such as ultrasound-, CT-, or MRI-
guided minimally invasive stereotactic biopsies can be suc-
cessfully performed for assessment of brain tumors.187
Complete removal of a brain tumor, however, depends on
factors such as the type of tumor, its location, and the ability
to accurately define resection boundaries. Although functional
MRI188,189 is a relatively better choice to differentiate whether
the tumor is too close to regions of brain that control motor
skills, it is often impossible owing to the low spatial resolu-
tion of MRI to determine exactly where the tumor ends and
normal brain tissue begins. In order to avoid removal of nor-
mal brain tissue, with increased risk of causing neurological
damage, neurosurgeons tend to be less aggressive and leave
significant portions of the tumor behind. Postsurgery conven-
tional or stereotactic radiation therapy is often sought to treat
the remaining tumor. Whether in craniotomy open skull sur-
gery or neuroendoscopy minimally invasive surgery, it is
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Boppart et al.190 and Bizheva et al.191 have reported on the
use of OCT to discriminate between healthy and pathological
human brain tissues. The use of a forward-imaging probe for
surgical guidance in this context has yet to be reported. We
believe that combining a narrow e.g., 1 mm high-speed
3D forward-imaging OCT needle probe with the existing low
resolution but large volume scan stereotactic systems can po-
tentially enhance tumor-related neurosurgical procedures
where precision and tissue conservation are of high priorities.
In addition to tumor removal or treatment, OCT-based im-
age guidance is also a natural fit with deep brain stimulation
procedures192 in which an electrode is placed within a specific
location of the brain for intermittent electrical stimulation.
Jafri et al.193 reported on such an application recently with a
side-imaging probe.
The technology of OCT-guided neurosurgery is in its in-
fancy. We expect this highly important area will see signifi-
cant progress in the near future.
6 Conclusions
Endoscopic OCT offers a means of obtaining high-resolution
and high-speed depth-resolved visualization of tissue struc-
tures in vivo. Its relative low cost and nondestructive nature
are highly attractive clinical advantages.
While side-imaging mode OCT endoscopes have been de-
veloped and applied for imaging in GI tract and vascular sys-
tems clinically, there remains a wide range of promising clini-
cal applications where OCT endoscopes can have significant
impact but where little or no clinical research have been re-
ported. The recent development of even smaller and more
efficient forward-imaging OCT endoscopes is exciting as the
probe size enters the range of needle sizes that are appropriate
for image-based surgical needle guidance.
We can also expect additional functional OCT methods,
such as molecular contrast OCT28,88 and birefringence
OCT86,87 to be employed in OCT endoscopes to provide ad-
ditional information.
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